A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA
Open Access
- 1 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 124 (5), 901-913
- https://doi.org/10.1038/s41416-020-01170-3
Abstract
Background The phytochemical mixture TriCurin (curcumin, epigallocatechin gallate (EGCG) and resveratrol) eliminates human papillomavirus (HPV) (+) cancer cells in vitro and in vivo. In this study, we further evaluate TriCurin. Methods The activity of TriCurin and its individual compounds was assayed on W12 cells, derived from a cervical precancer containing episomal and integrated HPV16 DNA, using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays, microscopy and reverse transcription-polymerase chain reaction (RT-PCR), and on HeLa cells by gene expression analysis. The stability and toxicity of TriCurin microemulsion were tested in an organotypic cervical tissue model. Results TriCurin and its individual compounds inhibit the growth of W12 cells, episomal, type 1 and 2 integrants; the relative order of activity is TriCurin, EGCG, curcumin, or resveratrol. RT-PCR shows that TriCurin activates p53 and suppresses HPV16 mRNAs E1, E2, E4, E6 and E7 at 24 h in W12 cells. Gene expression analysis shows that TriCurin activates pro-apoptotic genes and represses anti-apoptotic genes in HeLa cells. TriCurin in a microemulsion is stable and non-toxic to cervical tissue. The combination of TriCurin and tanshinone IIA exhibits additional synergy against HeLa cells. Conclusions TriCurin, and the combination of TriCurin with tanshinone IIA, are effective against HPV (+) cells. The phytochemical mixture, in the microemulsion-based cream, is a promising therapeutic for the prevention and treatment of cervical cancer.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (GM113782)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM113782)
This publication has 27 references indexed in Scilit:
- Actein induces calcium release in human breast cancer cellsFitoterapia, 2013
- Identification of a Calcium Signalling Pathway ofS-[6]-Gingerol in HuH-7 CellsEvidence-Based Complementary and Alternative Medicine, 2013
- Targeting Human Papillomavirus Genome Replication for Antiviral Drug DiscoveryAntiviral Therapy, 2013
- Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cellsProteomics, 2010
- Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell linesVirology, 2008
- The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathwaysInternational Journal of Cancer, 2007
- The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent ActivitiesCancer Research, 2007
- Actein and a Fraction of Black Cohosh Potentiate Antiproliferative Effects of Chemotherapy Agents on Human Breast Cancer CellsPlanta Medica, 2006
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI Journal of the National Cancer Institute, 2005
- Structure and transcription of human papillomavirus sequences in cervical carcinoma cellsNature, 1985